Bicara Therapeutics Inc. (BCAX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2023: $586.0K2024: $71.0K2025: $280.0K$280.0K
2023Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$280.0K+294.4%
2024$71.0K-87.9%
2023$586.0K